OB-GYN 101

Contents  ·  Introduction  ·  Learning Objectives  ·  Clinical Issues  ·  Procedures  ·  Library  ·  Pharmacy  ·  Lab  ·  Chest X-ray  ·  Ultrasound  ·  Videos  ·  Forms  ·  Progress Notes  ·  Facts Cards  ·  Students  ·  Feedback  ·  About Us

 

Vaginal Discharge

Overview
The diagnosis of vaginal discharge is based on a History, Physical Exam, and a few simple diagnostic tests.

History
Ask the patient about itching, odor, color of discharge, painful intercourse, or spotting after intercourse.

  • Yeast causes intense itching with a cheesy, dry discharge.

  • Gardnerella causes a foul-smelling, thin white discharge.

  • Trichomonas gives irritation and frothy white discharge.

  • Foreign body (lost tampon) causes a foul-smelling black discharge.

  • Cervicitis causes a nondescript discharge with deep dyspareunia

  • Chlamydia may cause a purulent vaginal discharge, post-coital spotting, and deep dyspareunia.

  • Gonorrhea may cause a purulent vaginal discharge and deep dyspareunia.

  • Cervical ectropion causes a mucous, asymptomatic discharge.

Physical Exam
Inspect carefully for the presence of lesions, foreign bodies and odor. Palpate to determine cervical tenderness.

  • Yeast has a thick white cottage-cheese discharge and red vulva.

  • Gardnerella has a foul-smelling, thin discharge.

  • Trichomonas has a profuse, bubbly, frothy white discharge.

  • Foreign body is obvious and has a terrible odor.

  • Cervicitis has a mucopurulent cervical discharge and the cervix is tender to touch.

  • Chlamydia causes a friable cervix but often has no other findings.

  • Gonorrhea causes a mucopurulent cervical discharge and the cervix may be tender to touch.

  • Cervical ectropion looks like a non-tender, fiery-red, friable button of tissue surrounding the cervical os.

  • Infected/Rejected IUD demonstrates a mucopurulent cervical discharge in the presence of an IUD. The uterus is mildly tender.

  • Chancroid appears as an ulcer with irregular margins, dirty-gray necrotic base and tenderness.

Laboratory

Obtain cultures for chlamydia, gonorrhea, and Strept. You may test the vaginal discharge in any of 4 different ways:

  • Test the pH. If >5.0, this suggests Gardnerella.

  • Mix one drop of KOH with some of the discharge on a microscope slide. The release of a bad-smelling odor confirms Gardnerella.

  • Examine the KOH preparation under the microscope ("Wet Mount"). Multiple strands of thread-like hyphae confirm the presence of yeast.

  • Mix one drop of saline with some discharge ("Wet Mount"). Under the microscope, large (bigger than WBCs), moving micro-organisms with four flagella are trichomonads. Vaginal epithelial cells studded with coccoid bacteria are "clue cells" signifying Gardnerella.

Read more about how to perform a wet mount.

Treatment

In addition to specific treatment of any organism identified by culture or other test...

  • Any patient complaining of an itchy vaginal discharge should probably be treated with an antifungal agent (Monistat, Lotrimin, etc.) because of the high likelihood that yeast is present, and

  • Any patient complaining of a bad-smelling vaginal discharge should probably be treated with Flagyl (or other reasonable substitute) because of the high likelihood that Gardnerella is present.

Ectropion, Erosion or Eversion
This harmless condition is frequently mistaken for cervicitis.

Ectropion, erosion or eversion (all synonyms) occurs when the normal squamo-columnar junction is extended outward from the its; normal position at the opening of the cervix.

Grossly, the cervix has a red, friable ring of tissue around the os. Careful inspection with magnification (6-10x) will reveal that this red tissue is the normal tissue of the cervical canal, which has grown out onto the surface of the cervix.

Cervical ectropion is very common, particularly in younger women and those taking BCPs. It usually causes no symptoms and need not be treated. If it is symptomatic, producing a more or less constant, annoying, mucous discharge, cervical cauterization will usually eliminate the problem.

When faced with a fiery red button of tissue surrounding the cervical os, chlamydia culture (in high-risk populations) and Pap smear should be performed. If these are negative and the patient has no symptoms, this cervical ectropion should be ignored.

Cervicitis
Inflammation or irritation of the cervix is rarely the cause of significant morbidity. It is mainly a nuisance to the patient and a possible symptom of underlying disease (gonorrhea, chlamydia).

Some patients with cervicitis note a purulent vaginal discharge, deep dyspareunia, and spotting after intercourse, while others may be symptom-free. The cervix is red, slightly tender, bleeds easily, and a mucopurulent cervical discharge from the os is usually seen.

A Pap smear rules out malignancy. Chlamydia culture and gonorrhea culture (for gram negative diplococci) are routinely performed.

No treatment is necessary if the patient is asymptomatic, the Pap smear is normal, and cultures are negative. Antibiotics specific to the organism are temporarily effective and may be curative. Cervical cautery may be needed to achieve permanent cure.

Chlamydia
This sexually-transmitted disease is caused by "chlamydia trachomatis". It very commonly locates in the cervical canal although it can spread to the fallopian tubes where it can cause PID.

Most women harboring chlamydia will have no symptoms, but others complain of purulent vaginal discharge, deep dyspareunia, and pelvic pain. There may be no significant pelvic findings, but a friable cervix, mucopurulent cervical discharge, pain on motion of the cervix, and tenderness in the adnexa are suggestive.

The diagnosis is often made on the basis of clinical suspicion but can be confirmed with chlamydia culture. Such cultures are frequently performed routinely in high-risk populations.

Treatment

Treating infected patients prevents transmission to sex partners. In addition, treating pregnant women usually prevents transmission of C. trachomatis to infants during birth. Treatment of sex partners helps to prevent reinfection of the index patient and infection of other partners.

Coinfection with C. trachomatis frequently occurs among patients who have gonococcal infection; therefore, presumptive treatment of such patients for chlamydia is appropriate (see Gonococcal Infection, Dual Therapy for Gonococcal and Chlamydial Infections). The following recommended treatment regimens and alternative regimens cure infection and usually relieve symptoms.

Recommended Regimens

Azithromycin 1 g orally in a single dose
   OR
Doxycycline 100 mg orally twice a day for 7 days

 

Alternative Regimens

Erythromycin base 500 mg orally four times a day for 7 days
   OR
Erythromycin ethylsuccinate 800 mg orally four times a day for 7 days
   OR
Ofloxacin 300 mg orally twice a day for 7 days
   OR
Levofloxacin 500 mg orally once daily for 7 days

CDC 2006 Treatment Guidelines

Read the CDC Treatment Guidelines for Chlamydia

 

Foreign Body
Lost and forgotten tampons are the most common foreign body found in the vagina, although other objects are occasionally found. Women with this problem complain of a bad-smelling vaginal discharge which is brown or black in color. The foreign body can be felt on digital exam or visualized with a speculum.

As soon as you suspect or identify a lost tampon or other object in the vagina, immediately prepare a plastic bag to receive the object. As soon as it is retrieved, place it in the bag and seal the bag since the anaerobic odor from the object will be extremely penetrating and long-lasting.

Have the patient return in a few days for follow-up examination. Normally, no other treatment is necessary, but patients who also complain of fever or demonstrate systemic signs/symptoms of illness should be evaluated for possible toxic shock syndrome, an extremely rare, but serious, complication of a retained tampon.

Gardnerella (Hemophilus, Bacterial Vaginosis)
The patient with this problem complains of a bad-smelling discharge which gets worse after sex. Cultures will show the presence of "Gardnerella Vaginalis," the bacteria associated with this condition. While this problem is commonly called "Gardnerella," it is probably the associated anaerobic bacteria which actually cause the bad odor and discharge.

The diagnosis is confirmed by the release of a bad odor when the discharge is mixed with KOH ("whiff test"), a vaginal pH greater than 5.0, or the presence of "clue cells" (vaginal epithelial cells studded with bacteria) in the vaginal secretions.

 

Treatment

Recommended Regimens

Metronidazole 500 mg orally twice a day for 7 days
   OR
Metronidazole gel, 0.75%, one full applicator (5 g) intravaginally, once a day for 5 days
   OR
Clindamycin cream, 2%, one full applicator (5 g) intravaginally at bedtime for 7 days

Patients should be advised to avoid consuming alcohol during treatment with metronidazole and for 24 hours thereafter. Clindamycin cream is oil-based and might weaken latex condoms and diaphragms for 5 days after use. Refer to clindamycin product labeling for additional information. Topical clindamycin preparations should not be used in the second half of pregnancy.

The recommended metronidazole regimens are equally efficacious. One randomized trial evaluated the clinical equivalency of intrav-aginal metronidazole gel 0.75% once daily versus twice daily and demonstrated similar cure rates 1 month after therapy (157).

Alternative Regimens

Clindamycin 300 mg orally twice a day for 7 days
   OR
Clindamycin ovules 100 mg intravaginally once at bedtime for 3 days

CDC 2006 Treatment Guidelines

Read the CDC Treatment Guidelines for Bacterial Vaginosis

Gonorrhea
This sexually-transmitted disease is caused by a gram negative diplococcus. The organism grows easily in the cervical canal, where it can spread to the fallopian tubes, causing PID. It may also infect the urethra, rectum or pharynx.

Many (perhaps most) women harboring the gonococcus will have no symptoms, but others complain of purulent vaginal discharge, pelvic pain, and deep dyspareunia. There may be no significant pelvic findings, but mucopurulent cervical discharge, pain on motion of the cervix, and tenderness in the adnexa are all classical.

The diagnosis is often made on the basis of clinical suspicion but can be confirmed with chocolate agar culture or gram stain.

Treatment

Ongoing data from CDC 's Gonococcal Isolate Surveillance Project (GISP), including preliminary findings from 2006, demonstrate that fluoroquinolone-resistant gonorrhea is continuing to spread and is now widespread in the United States. As a consequence, and as reported in the MMWR, April 13, 2007, this class of antibiotics is no longer recommended for the treatment of gonorrhea in the United States. Treatment recommendations have been updated accordingly, and are provided below.

Uncomplicated Gonococcal Infections of the Cervix, Urethra, and Rectum*

Recommended Regimens

Ceftriaxone 125 mg IM in a single dose
   OR
Cefixime 400 mg orally in a single dose or 400 mg by suspension (200 mg/5ml)
   
PLUS
TREATMENT FOR CHLAMYDIA IF CHLAMYDIAL INFECTION IS NOT RULED OUT

* These regimens are recommended for all adult and adolescent patients, regardless of travel history or sexual behavior.

Alternative Regimens

Spectinomycin† 2 g in a single intramuscular (IM) dose
   OR
Single-dose cephalosporin regimens

† Spectinomycin is currently not available in the United States.

Other single-dose cephalosporin therapies that are considered alternative treatment regimens for uncomplicated urogenital and anorectal gonococcal infections include ceftizoxime 500 mg IM; or cefoxitin 2 g IM, administered with probenecid 1 g orally; or cefotaxime 500 mg IM. Some evidence indicates that cefpodoxime 400 mg and cefuroxime axetil 1 g might be oral alternatives.

Uncomplicated Gonococcal Infections of the Pharynx*

Recommended Regimens

Ceftriaxone 125 mg IM in a single dose
    PLUS
TREATMENT FOR CHLAMYDIA IF CHLAMYDIAL INFECTION IS NOT RULED OUT

* This regimen is recommended for all adult and adolescent patients, regardless of travel history or sexual behavior.

Disseminated Gonococcal Infection (DGI)

Recommended Regimen

Ceftriaxone 1 g IM or IV every 24 hours

Alternative Regimens

Cefotaxime 1 g IV every 8 hours
OR
Ceftizoxime 1 g IV every 8 hours
OR
Spectinomycin† 2 g IM every 12 hour

† Spectinomycin is currently not available in the United States.

A cephalosporin-based intravenous regimen is recommended for the initial treatment of DGI. This is particularly important when gonorrhea is detected at mucosal sites by nonculture tests. Spectinomycin is not currently available in the United States; updated information regarding its availability can be found at http://www.cdc.gov/std/gonorrhea/arg.  Treatment should be continued for 24–48 hours after clinical improvement, at which time therapy may be switched to one of the following regimens to complete at least 1 week of antimicrobial therapy.

Cefixime  400 mg orally twice daily
   OR
Cefixime 400 mg by suspension (200 mg/5ml) twice daily
   OR
Cefpodoxime 400 mg orally twice daily
 

Fluoroquinolones may be an alternative treatment option if antimicrobial susceptibility can be documented by culture. With use of nonculture tests to diagnose N. gonorrhoeae increasing and with local data on antimicrobial susceptibility less available, laboratories should maintain the capacity to conduct such testing or form partnerships with laboratories that can.

CDC 2007 Treatment Guidelines

Read the CDC Treatment Guidelines for Gonorrhea

Infected IUD
Sooner or later, as many as 5% of all intrauterine devices will become infected. Patients with this problem usually notice mild lower abdominal pain, sometimes have a vaginal discharge and fever, and may notice deep dyspareunia. The uterus is tender to touch and one or both adnexa may also be tender.

Treatment consists of removal of the IUD and broad-spectrum antibiotics. If the symptoms are mild and the fever low-grade, oral antibiotics (amoxicillin, cephalosporins, tetracycline, etc.) are very suitable. If the patient's fever is high, the symptoms significant or she appears quite ill, IV antibiotics are a better choice (cefoxitin, or metronidazole plus gentamicin, or clindamycin plus gentamicin).

If an IUD is present and the patient is complaining of any type of pelvic symptom, it is wisest to remove the IUD, give antibiotics, and then worry about other possible causes for the patient's symptoms.

IUDs can also be rejected without infection. Such patients complain of pelvic pain and possibly bleeding. On pelvic exam, the IUD is seen protruding from the cervix. It should be grasped with an instrument and gently removed. It cannot be saved and should not be pushed back inside.

Read more about IUDs

PID: Mild
Gradual onset of mild bilateral pelvic pain with purulent vaginal discharge is the typical complaint. Fever <100.4 and deep dyspareunia are common.

Moderate pain on motion of the cervix and uterus with purulent or mucopurulent cervical discharge is found on examination. Gram-negative diplococci or positive chlamydia culture may or may not be present. WBC may be minimally elevated or normal.

Treatment

Oral therapy can be considered for women with mild-to-moderately severe acute PID, as the clinical outcomes among women treated with oral therapy are similar to those treated with parenteral therapy. Women who do not respond to oral therapy within 72 hours should be reevaluated to confirm the diagnosis and should be administered parenteral therapy on either an outpatient or in-patient basis.

Recommended Oral Regimen

Ceftriaxone 250 mg IM in a single dose
   PLUS
Doxycycline 100 mg orally twice a day for 14 days
   WITH OR WITHOUT
Metronidazole 500 mg orally twice a day for 14 days
  
 OR

Cefoxitin 2 g IM in a single dose and Probenecid, 1 g orally administered concurrently in a single dose
   PLUS
Doxycycline 100 mg orally twice a day for 14 days
   WITH OR WITHOUT
Metronidazole 500 mg orally twice a day for 14 days
  
 OR

Other parenteral third-generation cephalosporin (e.g., ceftizoxime or cefotaxime)
   PLUS
Doxycycline 100 mg orally twice a day for 14 days
   WITH OR WITHOUT
Metronidazole 500 mg orally twice a day for 14 days

Alternative Oral Regimens

If parenteral cephalosporin therapy is not feasible, use of fluoroquinolones (levofloxacin 500 mg orally once daily or ofloxacin 400 mg twice daily for 14 days) with or without metronidazole (500 mg orally twice daily for 14 days) may be considered if the community prevalence and individual risk (see “Gonococcal Infections in Adolescents and Adults” in Sexually Transmitted Disease Treatment Guidelines, 2006) of gonorrhea is low.  Tests for gonorrhea must be performed prior to instituting therapy and the patient managed as follows if the test is positive:

  • If NAAT test is positive, parenteral cephalosporin is recommended.
  • If culture for gonorrhea is positive, treatment should be based on results of antimicrobial susceptibility. If isolate is QRNG, or antimicrobial susceptibility can’t be assessed, parenteral cephalosporin is recommended.

Although information regarding other outpatient regimens is limited, amoxicillin/clavulanic acid and doxycycline or azithromycin with metronidazole has demonstrated short-term clinical cure. No data has been published regarding the use of oral cephalosporins for the treatment of PID.

CDC 2007 Treatment Guidelines

For further information, read the CDC Treatment Guidelines for PID

PID: Moderate to Severe
With moderate to severe PID, there is a gradual onset of moderate to severe bilateral pelvic pain with purulent vaginal discharge, fever >100.4 (38.0), lassitude, and headache. Symptoms more often occur shortly after the onset or completion of menses.

Excruciating pain on movement of the cervix and uterus is characteristic of this condition. Hypoactive bowel sounds, purulent cervical discharge, and abdominal dissension are often present. Pelvic and abdominal tenderness is always bilateral except in the presence of an IUD.

Gram-negative diplococci in cervical discharge or positive chlamydia culture may or may not be present. WBC and ESR are elevated.

Treatment consists of bedrest, IV fluids, IV antibiotics, and NG suction if ileus is present. Since surgery may be required, transfer to a definitive surgical facility should be considered.

Treatment

Parenteral Treatment

Parenteral and oral therapy appear to have similar clinical efficacy treating women with PID of mild or moderate severity. Clinical experience should guide decisions regarding transition to oral therapy, which usually can be initiated within 24 hours of clinical improvement.

Recommended Parenteral Regimen A

Cefotetan 2 g IV every 12 hours
   OR
Cefoxitin 2 g IV every 6 hours
   PLUS
Doxycycline 100 mg orally or IV every 12 hours

Recommmended Parenteral Regimen B

Clindamycin 900 mg IV every 8 hours
   PLUS
Gentamicin loading dose IV or IM (2 mg/kg of body weight), followed by a maintenance dose (1.5 mg/kg) every 8 hours. Single daily dosing may be substituted.


Alternative Parenteral Regimens

Ampicillin/Sulbactam 3 g IV every 6 hours
    PLUS
Doxycycline 100 mg orally or IV every 12 hours

CDC 2007 Treatment Guidelines

For further information, read the CDC Treatment Guidelines for PID

Trichomonas

This microorganism, with its four flagella to propel it, is not a normal inhabitant of the vagina. When present, it causes a profuse, frothy white or greenish vaginal discharge.

When the discharge is suspended in normal saline and examined under the microscope, the typical movement of these large organisms (larger than white blood cells) is obvious. Itching may be present, but this is inconsistent. Trichomonas is transmitted sexually and you may wish to treat the sexual partner, particularly if this is a recurrent trichomonad infection.

Treatment

Recommended Regimens

Metronidazole 2 g orally in a single dose
    OR
Tinidazole 2 g orally in a single dose


 

Alternative Regimen

Metronidazole 500 mg orally twice a day for 7 days

CDC 2006 Treatment Guidelines

Read the CDC Treatment Guidelines for Trichomonas

Yeast (Monilia, Thrush)
Vaginal yeast infections are common, monilial overgrowths in the vagina and vulvar areas, characterized by itching,dryness, and a thick, cottage-cheese appearing vaginal discharge. The vulva may be reddened and irritated to the point of tenderness.

Yeast thrives in damp, hot environments and women in such circumstances are predisposed toward these infections. Women who take broad-spectrum antibiotics are also predisposed towards these infections because of loss of the normal vaginal bacterial flora.

Yeast organisms are normally present in most vaginas, but in small numbers. A yeast infection, then, is not merely the presence of yeast, but the concentration of yeast in such large numbers as to cause the typical symptoms of itching, burning and discharge. Likewise, a "cure" doesn't mean eradication of all yeast organisms from the vagina. Even if eradicated, they would soon be back because that is where they normally live. A cure means that the concentration of yeast has been restored to normal and symptoms have resolved.

The diagnosis is often made by history alone, and enhanced by the classical appearance of a dry, cheesy vaginal discharge. It can be confirmed by microscopic visualization of clusters of thread-like, branching Monilia organisms when the discharge is mixed with KOH.

Treatment

Short-course topical formulations (i.e., single dose and regimens of 1–3 days) effectively treat uncomplicated VVC. The topically applied azole drugs are more effective than nystatin. Treatment with azoles results in relief of symptoms and negative cultures in 80%–90% of patients who complete therapy.

Recommended Regimens

Intravaginal Agents:

Butoconazole 2% cream 5 g intravaginally for 3 days*
   OR
Butoconazole 2% cream 5 g (Butaconazole1-sustained release), single intravaginal application
   OR
Clotrimazole 1% cream 5 g intravaginally for 7–14 days*
   OR
Clotrimazole 100 mg vaginal tablet for 7 days
   OR
Clotrimazole 100 mg vaginal tablet, two tablets for 3 days
   OR
Miconazole2% cream 5 g intravaginally for 7 days*
   OR
Miconazole 100 mg vaginal suppository, one suppository for 7 days*
   OR
Miconazole 200 mg vaginal suppository, one suppository for 3 days*
   OR
Miconazole 1,200 mg vaginal suppository, one suppository for 1 day*
   OR
Nystatin 100,000-unit vaginal tablet, one tablet for 14 days
   OR
Tioconazole 6.5% ointment 5 g intravaginally in a single application*
   OR
Terconazole 0.4% cream 5 g intravaginally for 7 days
   OR
Terconazole 0.8% cream 5 g intravaginally for 3 days
   OR
Terconazole 80 mg vaginal suppository, one suppository for 3 days

Oral Agent:


Fluconazole 150 mg oral tablet, one tablet in single dose

* Over-the-counter preparations.

CDC 2006 Treatment Guidelines

Reoccurrences are common and can be treated the same as for initial infections. For chronic recurrences, many patients find the use of a single applicator of Monistat 7 at the onset of itching will abort the attack completely. Sexual partners need not be treated unless they are symptomatic.

Read the CDC Treatment Guidelines for Yeast

 

 

OB-GYN 101: Introductory Obstetrics & Gynecology
© 2003, 2004, 2005, 2008 Brookside Associates, LLC
All rights reserved